-
One out of every 20 patients treated in United States hospitals for methicillin-resistant Staphylococcus aureus, or MRSA, in 2005 died from the infection.
-
Too few scientifically tested HIV prevention interventions target Latino men and women, and even fewer are specifically designed for Latino youth, an expert says.
-
HIV researchers who work with study participants who are injection drug users (IDUs) sometimes find themselves facing challenges that wouldn't be issues in the typical HIV trial.
-
HIV-infected patients have been shown to experience hypertriglyceridemia and/or hypercholesterolemia as a result of their highly active antiretroviral therapy (HAART), along with natural disease progression.
-
The Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States have undergone a complete revision and reorganization ...
-
Nationally, public health agencies are turning their focus to the HIV epidemic in the Latino community, but some say it's long overdue.
-
A major drawback to the routine use of abacavir in the treatment of HIV-1 infection is the occurrence of a hypersensitivity reaction in as many of 8% of recipients of this nucleoside analog reverse transcriptase inhibitor.
-
-
In this issue: Updated Immunization Guidelines from the CDC; Do antivirals have a role in the treatment of Bell's palsy? Topiramate is a promising treatment for alcohol dependence; and FDA Actions.
-
Dr. Thanassi is Associate Chief, Emergency Medicine; Director, Occupational Health, Palo Alto Veteran's Administration Hospital, and Dr. Menon is Section of Emergency Medicine, Stanford University Medical Center
